Sec. 1102. Public health and safety of women
1,037 words·~5 min read·
/bill/116/hr/1585/rh/section-1102A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
This section may be cited as the or the Stop Infant Mortality And Recidivism Reduction Act . SIMARRA Act Not later than 270 days after the date of the enactment of this section, the Director of the Federal Bureau of Prisons (in this section referred to as the Director ) shall establish a pilot program (in this section referred to as the Program ) in accordance with this section to permit women incarcerated in Federal prisons and the children born to such women during incarceration to reside together while the inmate serves a term of imprisonment in a separate housing wing of the prison.
The purposes of this section are to— prevent infant mortality among infants born to incarcerated mothers and greatly reduce the trauma and stress experienced by the unborn fetuses of pregnant inmates; reduce the recidivism rates of federally incarcerated women and mothers, and enhance public safety by improving the effectiveness of the Federal prison system for women as a population with special needs; establish female offender risk and needs assessment as the cornerstones of a more effective and efficient Federal prison system; implement a validated post-sentencing risk and needs assessment system that relies on dynamic risk factors to provide Federal prison officials with a roadmap to address the pre- and post-natal needs of Federal pregnant offenders, manage limited resources, and enhance public safety; perform regular outcome evaluations of the effectiveness of programs and interventions for federally incarcerated pregnant women and mothers to assure that such programs and interventions are evidence-based and to suggest changes, deletions, and expansions based on the results of such evaluations; and assist the Department of Justice to address the underlying cost structure of the Federal prison system and ensure that the Department can continue to run prison nurseries safely and securely without compromising the scope or quality of the Department’s critical health, safety and law enforcement missions.
The Director shall carry out this section in consultation with— a licensed and board-certified gynecologist or obstetrician; the Director of the Administrative Office of the United States Courts; the Director of the Office of Probation and Pretrial Services; the Director of the National Institute of Justice; and the Secretary of Health and Human Services. The Director shall, in accordance with paragraph (3)— develop an offender risk and needs assessment system particular to the health and sensitivities of Federally incarcerated pregnant women and mothers in accordance with this subsection; develop recommendations regarding recidivism reduction programs and productive activities in accordance with subsection (c); conduct ongoing research and data analysis on— the best practices relating to the use of offender risk and needs assessment tools particular to the health and sensitivities of federally incarcerated pregnant women and mothers; the best available risk and needs assessment tools particular to the health and sensitivities of Federally incarcerated pregnant women and mothers and the level to which they rely on dynamic risk factors that could be addressed and changed over time, and on measures of risk of recidivism, individual needs, and responsiveness to recidivism reduction programs; the most effective and efficient uses of such tools in conjunction with recidivism reduction programs, productive activities, incentives, and rewards; and which recidivism reduction programs are the most effective— for Federally incarcerated pregnant women and mothers classified at different recidivism risk levels; and for addressing the specific needs of Federally incarcerated pregnant women and mothers; on a biennial basis, review the system developed under subparagraph
(A)and the recommendations developed under subparagraph (B), using the research conducted under subparagraph (C), to determine whether any revisions or updates should be made, and if so, make such revisions or updates; hold periodic meetings with the individuals listed in paragraph
(1)at intervals to be determined by the Director; and report to Congress in accordance with subsection (i). In carrying out the duties under paragraph (2), the Director shall— consult relevant stakeholders; and make decisions using data that is based on the best available statistical and empirical evidence. An inmate may apply to participate in the Program if the inmate— is pregnant at the beginning of or during the term of imprisonment; and is in the custody or control of the Federal Bureau of Prisons. To correspond with the purposes and goals of the Program to promote bonding during the critical stages of child development, an eligible inmate selected for the Program may participate in the Program, subject to subsection (g), until the earliest of— the date that the inmate’s term of imprisonment terminates; the date the infant fails to meet any medical criteria established by the Director or the Director’s designee along with a collective determination of the persons listed in subsection (d)(1); or 30 months. For the duration of an inmate’s participation in the Program, the inmate shall agree to— take substantive steps towards acting in the role of a parent or guardian to any child of that inmate; participate in any educational or counseling opportunities established by the Director, including topics such as child development, parenting skills, domestic violence, vocational training, or substance abuse, as appropriate; abide by any court decision regarding the legal or physical custody of the child; transfer to the Federal Bureau of Prisons any child support payments for the infant of the participating inmate from any person or governmental entity; and specify a person who has agreed to take at least temporary custody of the child if the inmate’s participation in the Program terminates before the inmate’s release. The Director shall take appropriate actions to prevent detachment or disruption of either an inmate’s or infant’s health and bonding-based well-being due to termination of the Program. Not later than 6 months after the date of the enactment of this section and once each year thereafter for 5 years, the Director shall submit a report to the Congress with regards to progress in implementing the Program. Not later than 6 months after the termination of the Program, the Director shall issue a final report to the Congress that contains a detailed statement of the Director’s findings and conclusions, including recommendations for legislation, administrative actions, and regulations the Director considers appropriate. To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2020 through 2024.